Meeting
2023 ASCO Annual Meeting
Real-world analysis of cardiac, gastrointestinal, and hematologic toxicities between commonly used antiemetics in everyday oncology clinical practice.
Authors
Kavitha Beedupalli
Louisiana State University (Shreveport) Program at Feist-Weiller Cancer Center, Shreveport, LA
Kavitha Beedupalli , Anil Ananthaneni , Dawood Findakly
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Health Services Research and Quality Improvement
Track
Quality Care/Health Services Research
Sub Track
Real-World Data/Outcomes
Citation
J Clin Oncol 41, 2023 (suppl 16; abstr 6587)
DOI
10.1200/JCO.2023.41.16_suppl.6587
Abstract #
6587
Poster Bd #
79
Abstract Disclosures
Similar Posters
Poster
2020 ASCO Quality Care Symposium
Use of antiemetic prophylaxis and oral breakthrough medication for highly emetogenic chemotherapy (HEC) in a large community oncology network.
First Author: Garrett Young
Poster
2018 ASCO Quality Care Symposium
Efficacy of an antiemetic therapeutic interchange protocol driven by a medically integrated pharmacy.
First Author: Lalan S. Wilfong
Poster
2018 ASCO Annual Meeting
Efficacy of haloperidol versus olanzapine for control of chemotherapy induced nausea and vomiting.
First Author: Soniya Dulal
Poster
2023 ASCO Annual Meeting
Guideline-concordant use of olanzapine as part of a 4-drug antiemetic regimen for high emetic risk chemotherapy across the state of Michigan.
First Author: Ashley Bowen